GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Cyclically Adjusted Price-to-FCF

Kingworld Medicines Group (HKSE:01110) Cyclically Adjusted Price-to-FCF : 7.00 (As of Jun. 06, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Cyclically Adjusted Price-to-FCF?

As of today (2024-06-06), Kingworld Medicines Group's current share price is HK$0.56. Kingworld Medicines Group's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was HK$0.08. Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF for today is 7.00.

The historical rank and industry rank for Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

HKSE:01110' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 5   Med: 12   Max: 26.5
Current: 6.79

During the past 13 years, Kingworld Medicines Group's highest Cyclically Adjusted Price-to-FCF was 26.50. The lowest was 5.00. And the median was 12.00.

HKSE:01110's Cyclically Adjusted Price-to-FCF is ranked better than
82.39% of 176 companies
in the Healthcare Providers & Services industry
Industry Median: 23.74 vs HKSE:01110: 6.79

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Kingworld Medicines Group's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was HK$-0.117. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is HK$0.08 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kingworld Medicines Group Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Cyclically Adjusted Price-to-FCF Chart

Kingworld Medicines Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.90 12.80 9.71 10.56 7.78

Kingworld Medicines Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.71 - 10.56 - 7.78

Competitive Comparison of Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF falls into.



Kingworld Medicines Group Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=0.56/0.08
=7.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kingworld Medicines Group's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Kingworld Medicines Group's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.117/114.7809*114.7809
=-0.117

Current CPI (Dec23) = 114.7809.

Kingworld Medicines Group Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.014 99.000 -0.016
201512 0.169 100.600 0.193
201612 -0.059 102.600 -0.066
201712 0.061 104.500 0.067
201812 0.092 106.500 0.099
201912 0.202 111.200 0.209
202012 0.219 111.500 0.225
202112 0.045 113.108 0.046
202212 0.171 115.116 0.171
202312 -0.117 114.781 -0.117

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kingworld Medicines Group  (HKSE:01110) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Kingworld Medicines Group Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group (HKSE:01110) Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Executives
Chan Lok San 2101 Beneficial owner
Zhao Li Sheng 2101 Beneficial owner
Sinopharm Capital Limited 2201 Interest of corporation controlled by you
Sinopharm Healthcare Fund L.p. 2101 Beneficial owner
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you
Sun Hill Capital Investments Limited 2201 Interest of corporation controlled by you
Wu Aimin 2201 Interest of corporation controlled by you

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines